Todd Hembrough

Todd Hembrough is a seasoned executive and scientist in the oncology sector, currently serving as the Chief Executive Officer and co-founder of Nexosome Oncology since November 2021, focusing on innovative liquid biopsy solutions through extracellular vesicle proteomics. Prior to this role, Todd Hembrough held significant positions at AstraZeneca as Vice President of Oncology Translational Medicine and at OncoPlex Diagnostics as Chief Scientific Officer and Head of Research and Development. Todd Hembrough's career also includes leadership roles at OncoplexDx and EntreMed, where expertise in research and development was honed. Todd Hembrough completed a Ph.D. in Biochemistry at the University of Virginia and earned a B.S. in Zoology from the University of Rhode Island.